Fundraising

For Fundraising enquires please contact Anna on 020 7487 3892, email anna@cureparkinsons.org.uk or write to us at

120, Baker Street
London
W1U 6TU

Latest

Celebrating Tom - an evening of tributes and triumphs.

On 12th September, we celebrated the life and achievements of the wonderful Tom Isaacs - co-founder of The Cure Parkinson's Trust. Tom's incredible legacy remains at the absolute heart of the Trust.
The 'Tom Isaacs Award'

The Van Andel Research Institute and The Cure Parkinson’s Trust will introduce 'The Tom Isaacs Award' to be presented at the annual Grand Challenges in Parkinson’s and Rallying to the Challenge meeting on 27th & 28th September in Grand Rapids, Michigan.
The Tom Isaacs Charity Golf Day, Denham Golf Club

Our annual fundraising golf day will be taking place on Thursday 19th October 2017 at Denham Golf Club, Buckinghamshire.
Major gifts

Breakthrough in stem cell treatment for Parkinson's

In a major breakthrough for the treatment of Parkinson's, researchers working with laboratory rats show it is possible to make dopamine cells from embryonic stem cells and transplant them into the brain.
Tom Isaacs

We are devastated to announce that Tom Isaacs, President and Co-founder of The Cure Parkinson’s Trust (CPT) died on Wednesday morning (31st May). Tom’s passing was unexpected and swift.
New Evidence Suggests Parkinson's Might Not Start in The Brain

A new study adds to a raft of new evidence which suggests Parkinson's starts in the gut.
Trials - Repurposed drugs

Our Linked Clinical Trials initiative (LCT) identifies potential new treatments to slow, stop, or reverse Parkinson’s disease by 'repurposing' or repositioning drugs that are approved to treat other conditions.
Our story
Are Stem Cell-Based Therapies for Parkinson’s Disease Ready for the Clinic?

A research paper published in the Journal of Parkinson's Disease (Spring 2016) discusses an impending clinical trial in Parkinson's disease (PD) using parthenogenetic stem cells.
Apply for Funding
Breaking News: Diabetes Drug Shows Potential as Disease-Modifying Therapy for Parkinson’s

The study, published in The Lancet and funded by The Michael J. Fox Foundation for Parkinson’s Research (MJFF), supported by CPT found that people with Parkinson’s treated with Exenatide for one year performed better in motor tests than those on placebo.
The NAC Trial - the facts
Study links Parkinson's disease to Gut Bacteria

A new study finds that people with Parkinson's disease appear to have distinctly different gut bacteria.